Frozen vs. Fresh Donor Oocytes: Clinical Advantages in Modern IVF Practice

Written by: Kate Morgan

The historical preference for fresh donor oocytes was largely driven by the limitations of early oocyte cryopreservation protocols. However, with the widespread adoption of vitrification, that paradigm has shifted significantly. 

Frozen donor eggs now represent not only a viable alternative, but in many clinical scenarios, a more efficient and controlled option. 

Comparable (or Improved) Clinical Outcomes 

Vitrification has largely eliminated the gap in outcomes between fresh and frozen oocytes. Key observations include: 

• High post-thaw survival rates  
• Comparable fertilization rates 
• Similar blastocyst development rates  
• Comparable live birth rates per transfer 

Additionally, while fresh egg donation often results in more eggs overall, frozen cohorts allow for exclusion of oocytes with abnormal characteristics, thus increasing the overall quality of the purchased cohort of oocytes.  

“When someone donates, I expect 70 to 80 percent to be mature, so we’ve lost some eggs there,” says Wayne Caswell, Vice President of Laboratory Services with Fairfax EggBank. “Then, morphologically, some of those may be abnormal. There’s always going to be some variability there, which makes the egg number difference between frozen and fresh eggs an apples-to-oranges comparison.”  

Fairfax EggBank’s donor cohorts average a little more than six eggs, Caswell says, all of which are mature and pre-screened to ensure the highest quality.  

“Our techniques have improved so drastically over the last decade, it’s brought us close to even with the success rates of fresh donation,” says Dr. Wes Edmonds, Fairfax EggBank’s Scientific Director. “Using fresh donor eggs, we generally expect to get about three embryos per six eggs. With Fairfax EggBank cryopreserved eggs, we see about 2.8 embryos per egg cohort.” 

Decoupling of Donor and Recipient Cycles 

One of the most significant operational advantages is the elimination of cycle synchronization. Frozen oocytes allow clinics to instead schedule transfers based on optimal timing for the intended parent, avoid delays related to donor availability or variability in their response to medication, and reduce cycle cancellations or subpar outcomes related to poor donor stimulation.  

This decoupling improves both clinic efficiency and overall patient experience. 

“The really big advantage is the frozen donor eggs are available immediately,” Caswell says. “Screening is done, there are no concerns or unknowns for the recipient or risks of cancellation if a donor cycle goes bad. The risk of losing all that time and effort is eliminated.”  

This predictability supports better treatment planning and patient counseling, especially around cohort size, says Edmonds.  

“You may get more embryos in a fresh donor cycle, but then let’s say you end up with 10 or more embryos frozen. Ask yourself, is that what we want? That’s creating an ethical burden for patients to decide what to do with any embryos left in storage after they have finished building their family,” he says. “Patients may think more is better, but it’s part of the clinician’s job to counsel them about what that means from an ethical perspective.” 

Operational and Laboratory Efficiency 

From a lab and clinic management standpoint, frozen eggs offer more consistency, especially with Fairfax EggBank’s deep commitment to data monitoring, laboratory audits, and on-site training.  

“The enemy of quality is uncontrolled variability,” says Caswell. “We’re constantly identifying certain areas we know are wrought with variability, and anytime we can identify variables we can control or eliminate, our quality gets better.”  

Batch warming and fertilization protocols are standardized, enhancing lab efficiency, egg survival and embryo creation rates, and overall odds of success.  

“Our embryology team is closely involved in making sure each warming clinic has been appropriately trained with our protocols and that they understand how to handle the eggs. We ensure every step of the process is being completed correctly,” says Jennifer Hart, director of embryology relations. “That’s part of how we’re able to stand behind the guarantees we have in place.”  

Expanded Donor Accessibility  

Frozen egg banks significantly broaden donor availability, allowing patients to access a diverse pool of donors without geographic constraints. Fairfax EggBank maintains a catalog of more than 400 donors, chosen through a highly selective process that prioritizes genetic and cultural diversity.  

Donors have frozen eggs ready to be shipped immediately, which often drastically reduces wait times for recipients and improves patient satisfaction. This is particularly advantageous for clinics without in-house donor programs. 

The Big Picture  

Advancements in vitrification have fundamentally reshaped donor egg IVF. Frozen oocytes offer comparable clinical outcomes to fresh, while simultaneously increasing flexibility and efficiency and reducing risk. In short: they’re preferable for both patients and practitioners.  

“Ultimately, patients don’t care how many eggs they get. They don’t care how many fertilize. They care whether they have a chance at pregnancy,” says Caswell. 

“We want clinicians to be happy, and we want their patients to be happy,” he adds. “In their success is our success.”  

Frequently Asked Questions:  

What is the success rate using frozen eggs?  

Thanks to advances in vitrification, frozen eggs have a live birth rate around 40 percent, comparable to the success rates using fresh donor eggs in many clinics.  

When should I recommend my patients use frozen eggs?  

For patients looking to begin their cycle within weeks, who prioritize flexibility and a wider variety of available donors, frozen eggs are ideal. 

What are the cost considerations associated with frozen vs. fresh eggs? 

Frozen eggs are generally a more affordable option for patients, as they eliminate costs associated with synchronized donor and recipient cycles, including donor monitoring and travel. 

 About the Author

Kate Morgan is a science journalist whose work has appeared in The New York Times, The Washington Post, The Wall Street Journal, National Geographic, Popular Science, and many other publications. She lives in rural Pennsylvania, and tends a large garden and small children.